CEA-Leti And Akrivis Technologies To Develop Nanomedicine Platform For High Payload Targeted Drug Delivery
GRENOBLE, France--(BUSINESS WIRE)--CEA-Leti and Akrivis Technologies, LLC announced their collaboration to develop an extremely adaptable, efficient and highly targeted drug delivery platform for chemotherapy and other treatments that require a high concentration of powerful drugs to be delivered precisely to targeted cells.
Help employers find you! Check out all the jobs and post your resume.